SNAR-A1

Summary

SNAR-A1 (small NF90 (ILF3) associated RNA A1, HGNC:34304) is a gene on chromosome 19q13.33.

Predicted to be located in cytoplasm and nucleus.

Source: NCBI Gene 100126798 — RefSeq curated summary.

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:34304
Approved symbol	SNAR-A1
Name	small NF90 (ILF3) associated RNA A1
Location	19q13.33
Locus type	RNA, misc
Status	Approved
Aliases	SNAR-A53113498
Entrez	100126798
RNAcentral	URS00003848F7 — ncRNA, 122 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 0

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

None — 0 exons

Expression profiles

Top tissues by expression

0 total, by Bgee expression score (0-100, higher = more expressed):

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

• A noncanonical microRNA derived from the snaR-A noncoding RNA targets a metastasis inhibitor. (PMID:33795480)

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

Canonical reviewed UniProt: None (reviewed: )

All UniProt accessions (0):

RefSeq proteins (0): (*=MANE)

Domains & families (InterPro)

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 0 (showing top):

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

0 interactions, top by confidence:

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	0
Likely benign	0
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1158221722 (19:47917773 G>A,C,T), RS1159575364 (19:47917705 A>C), RS1161606641 (19:47917940 G>C), RS1164184846 (19:47918362 G>T), RS1166489433 (19:47917194 G>A), RS1167176387 (19:47917520 C>A,G), RS1169174987 (19:47917371 A>G,T), RS1169284727 (19:47917548 C>T), RS1170816008 (19:47917262 A>G), RS1170982855 (19:47918486 G>T), RS1172738894 (19:47917976 C>T), RS1172763276 (19:47918924 A>G), RS1173011855 (19:47918468 G>C,T), RS1174248685 (19:47917787 G>A,C), RS1175250472 (19:47917456 G>A,C,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

4 total (human), top 4 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
3,19-(2-bromobenzylidene)andrographolide	decreases expression, decreases response to substance	1
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide	decreases expression	1
Copper	affects binding, decreases expression	1
Disulfiram	decreases expression, affects binding	1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.